Tower Research Capital LLC (TRC) - CLARUS THERAPEUTICS HLDNGS I ownership

Back to all holdings Add to watchlist

CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L115. A total of 21 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q3 2022$0–910.0%0.00%–
Q2 2022$0–910.0%0.00%–
Q1 2022$0–910.0%0.00%–
Q4 2021$0–910.0%0.00%–
Q3 2021$0–91–0.00%–
 Download
Other shareholders
CLARUS THERAPEUTICS HLDNGS I shareholders Q4 2021
NameSharesValueWeighting ↓
Tower Research Capital LLC (TRC) 91$00.00%
NOMURA HOLDINGS INC 85,000$00.00%
Context Capital Management, LLC 62,175$00.00%
MIZUHO SECURITIES USA LLC 100,000$1,0000.00%
Caption Management, LLC 140,821$00.00%
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders